Monthly Archives: November 2024

NHS England will be relaunching their Pharmacy First public-facing campaign on Monday 11th October 2024. Minor revisions have been made to the original campaign materials used earlier this year, including additional information on the age criteria for the clinical pathways. Ahead of the official launch, the campaign materials are available on the Department of Health [...]

The post NHS England Pharmacy First campaign to re-start on Monday appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Nyzamac® SR 60mg capsules is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP076 Nyzamac® SR 60mg capsules expires at 23.59pm on Friday 8 November 2024. After this date, any prescriptions for Nyzamac® SR 60mg [...]

The post Expiry of SSP076 Nyzamac® SR 60mg capsules appeared first on Community Pharmacy England.

The Government has made The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Emergency Prohibition) (Extension) (No. 2) Order 2024, which has the effect of extending the ban, which was due to expire. The ban has been extended until 31 December 2024. The Secretary of State has expressed the intention to make the ban permanent, but can only do [...]

The post Legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues further extended appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited) Drug alert number: EL (24)A/53 Date issued: 07 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen [...]

The post MHRA Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited) appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 4 November 2024) has been published and includes articles on: MedSafetyWeek November 2024: your Yellow Card report helps prevent future harm to others and improves patient safety Letters and medicine recalls sent to healthcare professionals in October 2024 To see the [...]

The post MHRA Drug Safety Update: November 2024 appeared first on Community Pharmacy England.